Leeman-Neill, R. J., Bhagat, G., & Basu, U. (2024). AID in non-Hodgkin B-cell lymphomas: The consequences of on- and off-target activity. Nucleic Acid Associated Mechanisms in Immunity and Disease, 127–164. https://doi.org/10.1016/bs.ai.2024.03.005

Leeman-Neill, R. J., Song, D., Bizarro, J., Wacheul, L., Rothschild, G., Singh, S., Yang, Y., Sarode, A. Y., Gollapalli, K., Wu, L., Zhang, W., Chen, Y., Lauring, M. C., Whisenant, D. E., Bhavsar, S., Lim, J., Swerdlow, S. H., Bhagat, G., Zhao, Q., … Basu, U. (2023). Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression. Nature Genetics, 55(12), 2160–2174. https://doi.org/10.1038/s41588-023-01561-1

Gendreau, J. L., Patel, N., Brown, N. J., Lee, S. J., Sahyouni, R., Chan, A. K., Clifton, W. E., & Chen, S. (2023). Surgical Intervention for Primary B-cell Lymphoma of the Spine. Clinical Spine Surgery, 37(7), 296–304. https://doi.org/10.1097/bsd.0000000000001522

Wayne, A. S., Huynh, V., Hijiya, N., Rouce, R. H., Brown, P. A., Krueger, J., Kitko, C. L., Ziga, E. D., Hermiston, M. L., Richards, M. K., Baruchel, A., Schuberth, P. C., Rossi, J., Zhou, L., Goyal, L., Jain, R., Vezan, R., Masouleh, B. K., & Lee, D. W. (2022). Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia. Haematologica, 108(3), 747–760. https://doi.org/10.3324/haematol.2022.280678